Budapest, Hungary

Gergely M Makara

USPTO Granted Patents = 4 

Average Co-Inventor Count = 13.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
4 patents (USPTO):

Title: Gergely M Makara: Innovator in Anti-Diabetic Agents

Introduction

Gergely M Makara is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-diabetic agents. With a total of four patents to his name, his work focuses on innovative compounds that target critical health issues.

Latest Patents

Among his latest patents are cyclic benzimidazole derivatives that serve as activators of AMP-protein kinase. These novel compounds are designed to be useful in the treatment, prevention, and suppression of diseases mediated by the AMPK-activated protein kinase. Specifically, they are aimed at addressing Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension. The structural formula of these compounds highlights their potential in advancing therapeutic options for these prevalent health conditions.

Career Highlights

Gergely has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Metabasis Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in diabetes treatment.

Collaborations

Throughout his career, Gergely has collaborated with esteemed colleagues such as Qun Dang and Tony Gibson. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patented compounds.

Conclusion

Gergely M Makara stands out as a significant figure in the field of medicinal chemistry, particularly for his work on anti-diabetic agents. His innovative patents and collaborations reflect his commitment to addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…